Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Siga Technologies Inc (SIGA)

7.16   -0.03 (-0.42%) 01-21 00:06
Open: 7.19 Pre. Close: 7.19
High: 7.2099 Low: 7.07
Volume: 188,643 Market Cap: 554M
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.218 - 7.277 7.277 - 7.316
Low: 6.947 - 7.013 7.013 - 7.056
Close: 7.074 - 7.176 7.176 - 7.244

Technical analysis

as of: 2021-01-20 4:52:10 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.74     One year: 9.11
Support: Support1: 6.96    Support2: 5.79
Resistance: Resistance1: 7.48    Resistance2: 7.80
Pivot: 7.38
Moving Average: MA(5): 7.26     MA(20): 7.36
MA(100): 7.06     MA(250): 6.24
MACD: MACD(12,26): 0.02     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 15.70     %D(3): 24.86
RSI: RSI(14): 43.88
52-week: High: 8.10  Low: 3.96  Change(%): 37.4
Average Vol(K): 3-Month: 20857  10-Days: 18127

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SIGA has closed above bottom band by 17.5%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Jan 2021
Smallpox Treatment Market to Witness Massive Growth During 2021-2027 | Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., SIGA Technologies Inc., SIGA Technologies Inc. - Jumbo News

Wed, 20 Jan 2021
North America Biodefense Market Analysis, Trends, New Business Opportunities and Forecast 2021-2027 with Top Players Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies - NeighborWebSJ

Wed, 13 Jan 2021
SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX® - GlobeNewswire

Tue, 12 Jan 2021
Is SIGA Technologies, Inc.'s (NASDAQ:SIGA) Latest Stock Performance Being Led By Its Strong Fundamentals? - Simply Wall St

Wed, 06 Jan 2021
What is the Market's View on SIGA Technologies, Inc. (SIGA) Stock's Price and Volume Trends - InvestorsObserver

Tue, 22 Dec 2020
Read This Before Buying SIGA Technologies, Inc. (NASDAQ:SIGA) Shares - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 77
Shares Float (M) 39
% Held by Insiders 41.98
% Held by Institutions 38.47
Shares Short (K) 2,170
Shares Short P. Month (K) 2,500

Stock Financials

EPS 0.390
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.450
Profit Margin 34.62
Operating Margin 59.27
Return on Assets (ttm) 19.7
Return on Equity (ttm) 29.4
Qtrly Rev. Growth 445.7
Gross Profit (p.s.) 0.141
Sales Per Share 1.182
EBITDA (p.s.) 0.707
Qtrly Earnings Growth
Operating Cash Flow (M) 11
Levered Free Cash Flow (M) 4

Stock Valuations

PE Ratio 18.36
PEG Ratio
Price to Book value 4.94
Price to Sales 6.06
Price to Cash Flow 49.00

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.